Mark Johnson

Senior Director, Surgery Department
Mark Johnson

In addition to his duties as Senior Director of the Surgery Department, Mark is also the Senior Study Director at Charles River's Mattawan site. His areas of expertise include development of gene and cellular therapeutics for treatment of neurodegenerative and cardiovascular diseases, drug eluting coronary stents and other types of combination products, and development of small and large molecules requiring unique routes of administration to enhance the therapeutic benefit of the compound. Mark has presented and published extensively in the field of safety and efficacy studies with various biologic, pharmaceutical and medical devices.


Can We Wound Biofilms?

These complex 3D structures of bacteria explain many of the challenges clinicians face with wound care, infection and healing. Scientists are fighting back.

|
Mark Johnson